"There's no other competitor that does this as well as Veeva."
Motley Fool contributor Jamie Louko keeps buying Veeva Systems (VEEV -0.71%) stock. Veeva has a strong moat, as pharmaceutical and biotech companies rely on its products heavily and rarely leave.
Check out the video for his full thoughts!
*Stock prices used were the midday prices of Jan. 22, 2023. The video was published on Jan. 23, 2023.
Jamie Louko has positions in Veeva Systems. Zane Fracek has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Veeva Systems. The Motley Fool has a disclosure policy. Zane Fracek and Jamie Louko are affiliates of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through their link, they will earn some extra money that supports their channel. Their opinions remain their own and are unaffected by The Motley Fool.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
